Health Catalyst Gross Margin 2018-2024 | HCAT
Current and historical gross margin for Health Catalyst (HCAT) over the last 10 years. The current gross profit margin for Health Catalyst as of December 31, 2024 is %.
| Health Catalyst Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-12-31 | $0.31B | $0.14B | 45.93% |
| 2024-09-30 | $0.30B | $0.14B | 45.36% |
| 2024-06-30 | $0.30B | $0.14B | 45.00% |
| 2024-03-31 | $0.30B | $0.13B | 44.78% |
| 2023-12-31 | $0.30B | $0.13B | 44.93% |
| 2023-09-30 | $0.29B | $0.13B | 45.86% |
| 2023-06-30 | $0.28B | $0.13B | 46.83% |
| 2023-03-31 | $0.28B | $0.14B | 47.87% |
| 2022-12-31 | $0.28B | $0.13B | 48.19% |
| 2022-09-30 | $0.27B | $0.13B | 48.90% |
| 2022-06-30 | $0.27B | $0.13B | 48.87% |
| 2022-03-31 | $0.26B | $0.12B | 48.63% |
| 2021-12-31 | $0.24B | $0.12B | 48.97% |
| 2021-09-30 | $0.23B | $0.12B | 49.78% |
| 2021-06-30 | $0.22B | $0.11B | 50.46% |
| 2021-03-31 | $0.20B | $0.10B | 49.75% |
| 2020-12-31 | $0.19B | $0.09B | 48.40% |
| 2020-09-30 | $0.18B | $0.09B | 48.04% |
| 2020-06-30 | $0.17B | $0.08B | 49.12% |
| 2020-03-31 | $0.17B | $0.08B | 50.30% |
| 2019-12-31 | $0.16B | $0.08B | 51.61% |
| 2019-06-30 | $0.11B | $0.05B | 50.48% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.305B | $0.296B |
| Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.709B | 54.09 |
| Hims & Hers Health (HIMS) | United States | $11.210B | 183.25 |
| Tempus AI (TEM) | United States | $10.954B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.532B | 107.78 |
| IRhythm Technologies (IRTC) | United States | $3.734B | 0.00 |
| Privia Health (PRVA) | United States | $2.941B | 245.10 |
| Enovis (ENOV) | United States | $2.475B | 16.49 |
| Clover Health Investments (CLOV) | United States | $2.095B | 0.00 |
| Azenta (AZTA) | United States | $2.083B | 96.98 |
| Omnicell (OMCL) | United States | $1.845B | 40.23 |
| Schrodinger (SDGR) | United States | $1.580B | 0.00 |
| Phreesia (PHR) | United States | $1.577B | 0.00 |
| 10x Genomics (TXG) | United States | $1.381B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.859B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.512B | 0.00 |
| Standard BioTools (LAB) | United States | $0.495B | 0.00 |
| Talkspace (TALK) | United States | $0.481B | 285.00 |
| TruBridge (TBRG) | United States | $0.423B | 123.26 |
| Nyxoah SA (NYXH) | Belgium | $0.353B | 0.00 |
| Pulmonx (LUNG) | United States | $0.352B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.257B | 0.00 |
| American Well (AMWL) | United States | $0.174B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.085B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| 111 (YI) | China | $0.072B | 0.00 |
| CareCloud (CCLD) | United States | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| Movano (MOVE) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |